Lonza's Synaffix and Qurient Therapeutics Unite for Innovative ADC Development Lonza's Synaffix collaborates with Qurient Therapeutics to advance dual-payload ADCs aimed at targeting tough cancers, marking a significant step in medical innovation.

Lonza's Synaffix and Qurient Therapeutics Unite for Innovative ADC Development #None #Synaffix #Lonza #Qurient #Amsterdam,_Seongnam-si